← Evidence map

ArticleClinical pharmacokinetics2021

Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist.

Benjamin Berger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2021
2022
2023
2024
2025
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34002356